Search Results 281-290 of 22936 for Lateral
... Lateral Sclerosis (ALS) and Healthy Volunteers (HV). Jacksonville, Fla. The purpose of this study is to evaluate the safety, pharmacokinetics and ...
... Lateral Sclerosis (ALS). Two escalating dose (low dose and high dose) cohorts are planned. The duration of the study will be a maximum of 5 years and 5 ...
... Lateral Sclerosis (ALS). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...
On the left, MRI of a 16-year-old boy with patellofemoral instability shows lateral displacement of the patella. On the right, a postoperative image shows ...
For amyotrophic lateral sclerosis (ALS):. Adults—At first, one packet per day for 3 weeks. After 3 weeks, your doctor may increase your dose to one packet 2 ...
The findings shed new light on the link between culprits implicated in two devastating neurological diseases: frontotemporal dementia and amyotrophic lateral ...
... lateral lumbar interbody fusion procedure performed at one or two contiguous levels. Data obtained will be used to support publication and podium ...
The purpose of this study is to develop a natural history dataset and biorepository of early Primary Lateral Sclerosis (PLS) and well-established PLS cases for ...
Immune Phenotyping in Amyotrophic Lateral Sclerosis. Rochester, Minn. The goals of this study are to identify biomarkers that allow improved staging or ...
Meralgia paresthetica (also called lateral femoral cutaneous nerve entrapment); Sacroiliitis · Sciatica. Cancer. Bone metastasis (advanced cancer that has ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.